Evidence map›Paper›PMID 33331017›Full record

ArticleDermatologic therapy2021

Alopecia areata in a COVID-19 patient: A case report.

Alessandro Capalbo, Domenico Giordano, Nazareno Gagliostro, Charalampos Georgios Balampanos, Flavia Persechino, Federica Orrù, Severino Persechino

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatologic therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs.Clinical, cosmetic and investigational dermatology · 2023
    Review
  10. Article
  11. Factors associated with development and persistence of post-COVID conditions: A cross-sectional study.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Alopecia areata after COVID-19 vaccination.Clinical and experimental vaccine research · 2022
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alessandro CapalboNESMOS Department, Dermatology Unit, Sant' Andrea Hospital Faculty of Medicine and Psychology Roma, Sapienza University of Rome, Rome, Italy.
Domenico GiordanoNESMOS Department, Dermatology Unit, Sant' Andrea Hospital Faculty of Medicine and Psychology Roma, Sapienza University of Rome, Rome, Italy.
Nazareno GagliostroNESMOS Department, Dermatology Unit, Sant' Andrea Hospital Faculty of Medicine and Psychology Roma, Sapienza University of Rome, Rome, Italy.
Charalampos Georgios BalampanosNESMOS Department, Dermatology Unit, Sant' Andrea Hospital Faculty of Medicine and Psychology Roma, Sapienza University of Rome, Rome, Italy.
Flavia PersechinoDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Federica OrrùSant' Andrea Hospital Faculty of Medicine and Psychology Roma, Sapienza University of Rome, Rome, Italy.
Severino PersechinoNESMOS Department, Dermatology Unit, Sant' Andrea Hospital Faculty of Medicine and Psychology Roma, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-3728-5877

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alopecia AreataCOVID-19HumansSARS-CoV-2

Identifiers

PMID33331017
PMCPMC7883233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.